Locally advanced |
Control |
Epirubicin |
75 mg/m², d 1 |
Every 3 weeks for 4 cycles |
de Matteis A, 2002 |
|
|
Docetaxel |
80 mg/m², d 1 |
|
|
|
Experimental |
Epirubicin |
30 mg/m², dd 1-8-15 |
Every 4 weeks for 3 cycles |
Wenzel C, 2002 |
|
|
Docetaxel |
35 mg/m², dd 1-8-15 |
|
|
|
Metastatic, no previous anthracyclines |
Control |
Epirubicin |
60 mg/m², d 1 |
Every 3 weeks for 6 cycles |
Trudeau ME, 1999 |
|
|
Docetaxel |
75 mg/m², d 1 |
|
|
|
Experimental |
Epirubicin |
25 mg/m², dd 1-8-15 |
Every 4 weeks for 6 cycles |
Wenzel C, 2002 |
|
|
Docetaxel |
30 mg/m², dd 1-8-15 |
|
|
|
Metastatic, previously treated with anthracyclines |
Control |
Capecitabine |
1000 mg/m², b.i.d., dd 1-14 |
Every 3 weeks for 6 cycles |
Pronk LC, 2000 |
|
|
Docetaxel |
75 mg/m², d 1 |
|
|
|
Experimental |
Capecitabine |
625 mg/m², b.i.d., dd 5-18 |
Every 4 weeks for 6 cycles |
Nadella P, 2002 |
|
|
Docetaxel |
35 mg/m², dd 1-8-15 |
|
|